ArticleCell death discovery2023

Midkine inhibition enhances anti-PD-1 immunotherapy in sorafenib-treated hepatocellular carcinoma via preventing immunosuppressive MDSCs infiltration.

Lijuan Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.